123asd
- 24 Oct 2011 07:34
XEN is about to conclude two company-transforming deals:
- with Synbio, a Russian sovereign-wealth backed company
- with the similar sounding SymbioTech - a German biopharma
js8106455
- 13 May 2013 14:38
- 3 of 3
Listen to Scott Maguire, CEO, Xenetic Biosciences discussing the commencement of phase II with MyeloXenT.
CLICK HERE TO LISTEN